際際滷

際際滷Share a Scribd company logo
LEPTOSPIROSIS - DIAGNOSIS & MANAGEMENT GUIDELINES
MODIFIED FAINES CRITERIA (2012)
PRESUMPTIVE DIAGNOSIS: PART A or PART (A+B) = 26 or more
PART (A+B+C) = 25 or more
POSSIBLE DIAGNOSIS: Scores between 20 and 25
CASE DEFINITION (ICMR & WHO-SEAR)
Suspected case Acute febrile illness with:
Myalgia (especially calf tenderness)
Conjunctival su
ff
usion
Headache
Prostration
History of exposure to possible leptospira-contaminated environment
Probable case Suspected case with:
Rapid diagnostic test positivity (IgM ELISA or MSAT)
Con
fi
rmed case Suspected or Probable case with:
Isolation of leptospira in culture or
PCR positivity or
MAT (single titre of 1:400 or above / fourfold rise in serial titres)
CLINICAL
(PART-A)
EPIDEMIOLOGICAL
(PART-B)
LABORATORY
(PART-C)
Headache 2 Rainfall 5 Isolation by
culture**
DIAGNOSIS
CERTAIN
Fever 2 Contact with
contaminated
environment
4 Positive PCR 25
Temperature
> 39* C
2 Animal contact 1 ELISA IgM
Positive*
15
Conjunctival
su
ff
usion
4 MSAT Positive* 15
Meningism 4 MAT*
(Single high
titre or Rising
titre - 4x rise)
15
Myalgia 4
Conjunctival
su
ff
usion +
Meningism +
Myalgia
10 *any one of the
tests only should
be considered
for scoring
Jaundice 1
Albuminuria /
Azotemia
2
Hemoptysis /
Dyspnea
2
**Ideal time for culture
Blood - Within 10 days
Urine - 10 to 30 days
CSF - Within 5 to 10 days
Leptospirosis - Suspected / Probable / Con
fi
rmed
90% of cases are
Mild Leptospirosis
(Fever, myalgia,
conjunctival suffusion,
headache BUT NO
JAUNDICE)
Around 10% cases are
Moderate / Severe Leptospirosis
(Fever, myalgia, conjunctival suffusion, headache + JAUNDICE +/-
Multi-organ involvement
Based on clinical
spectrum
OP Treatment
Doxycycline 100mg PO
BD x 7 days or
Amoxicillin 500mg PO
TDS x 7 days or
Ampicillin 500mg
PO TDS x 7days or
Azithromycin 500mg PO
OD x 3 days
Other supportive Rx*
*advise adequate
hydration, bed rest,
antipyretics etc.
RED FLAG SIGNS
(tachypnea, tachycardia
disproportionate to fever,
shock, altered sensorium,
oliguria, bleeding
manifestations etc.)
IP Treatment (Antibiotic Rx +/- Organ speci
fi
c Rx)
Antibiotic therapy:
Penicillin 1.5 million units IV QID x 7 days or
Ceftriaxone 1g IV BD x 7 days or
Doxycycline 200mg IV stat, then 100mg IV BD x 7days
(Doxycycline contraindicated in pregnancy)
Organ speci
fi
c therapy:
RENAL: renal involvement is common.
Mild - only proteinuria and no RFT derangement: No intervention
Severe - AKI: Fluid management +/- diuretics, electrolyte correction,
avoid nephrotoxic drugs, avoid hypotension and hypovolemia +/- RRT (if
indicated by standard RRT guidelines)
HEPATIC: acute liver failure is rare.
Avoid precipitating factors of hepatic encephalopathy - drugs
(hepatotoxic drugs, sedatives etc.), hypovolemia, hypokalemia,
alkalosis, constipation, UGI bleeding.
Jaundice, Hepatomegaly: No intervention
Hepatic encephalopathy: lactulose, rifaximin etc.
LUNG: Most dangerous complication
ARDS / Pulmonary hemorrhage: Continuous O2 therapy, Mechanical
ventilation (if indicated)
HEART:
Myocarditis / Arrhythmia: treatment of speci
fi
c arrhythmia
Shock: treat hypovolemia with
fl
uid replacement. If not responding, add
dopamine or dobutamine.
HEMATOLOGICAL:
Thrombocytopenia: Platelet transfusion (if indicated)
Coagulopathy: Vit.K 5-10mg IV x 3 days +/- Fresh Frozen Plasma
DIC: FFP +/- blood transfusion
NEUROLOGICAL:
Aseptic meningitis: Symptomatic and supportive management.
Hypokalemic paralysis: IV Potassium supplementation
MUSCULOSKELETAL:
Myalgia / Myositis / Rhabdomyolysis : Monitor CPK levels, adequate
hydration, monitor urine output and serum electrolytes.
Arthralgia: No intervention +/- analgesic-antipyretics
All Absent
Any one or more is
present
Always rule out other tropical diseases.
Mixed infections are common.
Important differential diagnosis include:
-Malaria
-Scrub typhus
-Dengue
-Hepatitis
-Enteric fever etc.
Leptospirosis
 Zoonotic
 Pathogenic spirochete  Leptospira interrogans
 Rodents and Cattle excrete these organisms in their urine, which contaminates soil and
waterbodies
 Mode of transmission: contact of abraded skin or mucous membrane with contaminated
environment
 Incubation period: Average 5-14 days with a range 2- 30 days
 Risk factors:
o Heavy rainfall and water logging
o Natural disasters like floods
o Seasonal  at the onset of monsoon
o Farmers
o Agricultural field workers
o Fishermen
o Sewer workers
o Livestock handlers
o Mason
o Residence in endemic area
 Presentation spectrum:
o Anicteric Leptospirosis: (90%)  Mild form presents like Acute undifferentiated fever
o Icteric Leptospirosis: (5-10%)  Moderate-Severe form
o Weils Disease (0-5%)  Severe form
 When to suspect Leptospirosis?
o Acute febrile illness + Risk factors + one or more of the following:
 Headache
 Myalgia
 Prostration
 Calf muscle tenderness
 Conjunctival suffusion
 Oliguria / Frothy urine
 Jaundice
 Haemorrhagic manifestations
 Meningeal irritation
 Nausea, Vomiting, Abdominal pain, Diarrhoea
 Lab investigations to support diagnosis: (Blood, CSF, Urine sample)
o MAT titre of 100/200/400 or above based on endemicity (preferred)
o IgM based immune assays
o Seroconversion or Four-fold rise in MAT titre between acute and convalescent sera
o Direct isolation of organism
o PCR test
 Lab investigations to assess severity:
o CBC, ESR
o RFT, LFT
o S. Electrolytes
o Urine Routine examination
o CPK
o CXR, ABG
 Management:
o IVF and correction of electrolytes
o Mild cases:
 Tab. Doxycycline 100mg PO BD X 7 days (preferred) or
 Tab. Azithromycin 500mg PO OD X 3 days
o Moderate / Severe cases:
 Inj. Penicillin 1.5 million units IV or IM Q6H X 7 days or
 Inj. Ceftriaxone 2g IV OD X 7 days
o Chemoprophylaxis:
 Tab. Doxycycline 200mg PO once a week or
 Tab. Azithromycin 250mg PO once/ twice a week
DIAGNOSTIC:
A + B = /> 26
OR
A + B + C = /> 25
POSSIBLE:
A + B = Between 20 to 25
CRITERIA

More Related Content

Similar to Leptospirosis Protocol for NABH accredition (20)

Malaria clinical features
Malaria clinical featuresMalaria clinical features
Malaria clinical features
Prathik B H Gowda
D E N G U E- definition, clinical manifestations
D E N G U E-  definition, clinical manifestationsD E N G U E-  definition, clinical manifestations
D E N G U E- definition, clinical manifestations
NandhanaNandy
Antibiotics
AntibioticsAntibiotics
Antibiotics
shabeel pn
Severe Malaria; Clinical Features and Management.pptx
Severe Malaria; Clinical Features and Management.pptxSevere Malaria; Clinical Features and Management.pptx
Severe Malaria; Clinical Features and Management.pptx
Yusuf Dikko
Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
Bng Crz
Dhf
DhfDhf
Dhf
Asst.Prof.Dr.Terdsak Rojsurakitti
Neonatal sepsis ppp
Neonatal sepsis pppNeonatal sepsis ppp
Neonatal sepsis ppp
Mohamed Eisam Elhag
interpretation-of-CBC WBCLYPHMCVHGB.pptx
interpretation-of-CBC WBCLYPHMCVHGB.pptxinterpretation-of-CBC WBCLYPHMCVHGB.pptx
interpretation-of-CBC WBCLYPHMCVHGB.pptx
jawaraliyi2020
Renal Disorders.pptx
Renal Disorders.pptxRenal Disorders.pptx
Renal Disorders.pptx
Tashriiq_Ahmed
Dengue Cu Resident 01 2010
Dengue Cu Resident 01 2010Dengue Cu Resident 01 2010
Dengue Cu Resident 01 2010
thawat nganrungraung
Infective Endocarditis Pediatrics
Infective Endocarditis PediatricsInfective Endocarditis Pediatrics
Infective Endocarditis Pediatrics
PradeepKumar874784
S Lecture
S LectureS Lecture
S Lecture
drmomusa
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld, PharmD
8. Nephrotic Syndrome & AcuteGlomerularNephritis
8. Nephrotic Syndrome & AcuteGlomerularNephritis8. Nephrotic Syndrome & AcuteGlomerularNephritis
8. Nephrotic Syndrome & AcuteGlomerularNephritis
Whiteraven68
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandip
Sandip Gupta
Blood transfusion Reactions Path - SLIDE SHARE.pptx
Blood transfusion Reactions Path - SLIDE SHARE.pptxBlood transfusion Reactions Path - SLIDE SHARE.pptx
Blood transfusion Reactions Path - SLIDE SHARE.pptx
VishnuPrasad438933
Acquired heart diseases...............ppt
Acquired heart diseases...............pptAcquired heart diseases...............ppt
Acquired heart diseases...............ppt
Ahmed Kitaw
Diagnosis and examination of swollen lymph nodes ppt.pptx
Diagnosis and examination of swollen lymph nodes ppt.pptxDiagnosis and examination of swollen lymph nodes ppt.pptx
Diagnosis and examination of swollen lymph nodes ppt.pptx
riazsohail448
Acute Pancreatitis
Acute Pancreatitis Acute Pancreatitis
Acute Pancreatitis
Palatty Jinto
Fever,Rash and.pptx
Fever,Rash and.pptxFever,Rash and.pptx
Fever,Rash and.pptx
zahramoukhader
Malaria clinical features
Malaria clinical featuresMalaria clinical features
Malaria clinical features
Prathik B H Gowda
D E N G U E- definition, clinical manifestations
D E N G U E-  definition, clinical manifestationsD E N G U E-  definition, clinical manifestations
D E N G U E- definition, clinical manifestations
NandhanaNandy
Antibiotics
AntibioticsAntibiotics
Antibiotics
shabeel pn
Severe Malaria; Clinical Features and Management.pptx
Severe Malaria; Clinical Features and Management.pptxSevere Malaria; Clinical Features and Management.pptx
Severe Malaria; Clinical Features and Management.pptx
Yusuf Dikko
Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
Bng Crz
interpretation-of-CBC WBCLYPHMCVHGB.pptx
interpretation-of-CBC WBCLYPHMCVHGB.pptxinterpretation-of-CBC WBCLYPHMCVHGB.pptx
interpretation-of-CBC WBCLYPHMCVHGB.pptx
jawaraliyi2020
Renal Disorders.pptx
Renal Disorders.pptxRenal Disorders.pptx
Renal Disorders.pptx
Tashriiq_Ahmed
Infective Endocarditis Pediatrics
Infective Endocarditis PediatricsInfective Endocarditis Pediatrics
Infective Endocarditis Pediatrics
PradeepKumar874784
S Lecture
S LectureS Lecture
S Lecture
drmomusa
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld, PharmD
8. Nephrotic Syndrome & AcuteGlomerularNephritis
8. Nephrotic Syndrome & AcuteGlomerularNephritis8. Nephrotic Syndrome & AcuteGlomerularNephritis
8. Nephrotic Syndrome & AcuteGlomerularNephritis
Whiteraven68
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandip
Sandip Gupta
Blood transfusion Reactions Path - SLIDE SHARE.pptx
Blood transfusion Reactions Path - SLIDE SHARE.pptxBlood transfusion Reactions Path - SLIDE SHARE.pptx
Blood transfusion Reactions Path - SLIDE SHARE.pptx
VishnuPrasad438933
Acquired heart diseases...............ppt
Acquired heart diseases...............pptAcquired heart diseases...............ppt
Acquired heart diseases...............ppt
Ahmed Kitaw
Diagnosis and examination of swollen lymph nodes ppt.pptx
Diagnosis and examination of swollen lymph nodes ppt.pptxDiagnosis and examination of swollen lymph nodes ppt.pptx
Diagnosis and examination of swollen lymph nodes ppt.pptx
riazsohail448
Acute Pancreatitis
Acute Pancreatitis Acute Pancreatitis
Acute Pancreatitis
Palatty Jinto
Fever,Rash and.pptx
Fever,Rash and.pptxFever,Rash and.pptx
Fever,Rash and.pptx
zahramoukhader

More from Manievelraaman Kannan (10)

Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESSManievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
Manievelraaman Kannan
Parkinson Plus Syndrome - Multiple System Atrophy: Case Report
Parkinson Plus Syndrome - Multiple System Atrophy: Case ReportParkinson Plus Syndrome - Multiple System Atrophy: Case Report
Parkinson Plus Syndrome - Multiple System Atrophy: Case Report
Manievelraaman Kannan
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome
Allergy Induced Acute Coronary Syndrome - Kounis SyndromeAllergy Induced Acute Coronary Syndrome - Kounis Syndrome
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome
Manievelraaman Kannan
Brugada Syndrome - A Cardiac Channelopathy: Case Report
Brugada Syndrome - A Cardiac Channelopathy: Case ReportBrugada Syndrome - A Cardiac Channelopathy: Case Report
Brugada Syndrome - A Cardiac Channelopathy: Case Report
Manievelraaman Kannan
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Manievelraaman Kannan
TB Myeloradiculopathy
TB MyeloradiculopathyTB Myeloradiculopathy
TB Myeloradiculopathy
Manievelraaman Kannan
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGNCOLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
Manievelraaman Kannan
Allergic Acute Coronary Syndrome - KOUNIS SYNDROME
Allergic Acute Coronary Syndrome - KOUNIS SYNDROMEAllergic Acute Coronary Syndrome - KOUNIS SYNDROME
Allergic Acute Coronary Syndrome - KOUNIS SYNDROME
Manievelraaman Kannan
Abnormal Uterine Bleeding (AUB) -Etiopathogenesis
Abnormal Uterine Bleeding (AUB) -EtiopathogenesisAbnormal Uterine Bleeding (AUB) -Etiopathogenesis
Abnormal Uterine Bleeding (AUB) -Etiopathogenesis
Manievelraaman Kannan
Small Intestine TB (Tuberculosis)
Small Intestine TB (Tuberculosis)Small Intestine TB (Tuberculosis)
Small Intestine TB (Tuberculosis)
Manievelraaman Kannan
Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESSManievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
Manievelraaman Kannan
Parkinson Plus Syndrome - Multiple System Atrophy: Case Report
Parkinson Plus Syndrome - Multiple System Atrophy: Case ReportParkinson Plus Syndrome - Multiple System Atrophy: Case Report
Parkinson Plus Syndrome - Multiple System Atrophy: Case Report
Manievelraaman Kannan
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome
Allergy Induced Acute Coronary Syndrome - Kounis SyndromeAllergy Induced Acute Coronary Syndrome - Kounis Syndrome
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome
Manievelraaman Kannan
Brugada Syndrome - A Cardiac Channelopathy: Case Report
Brugada Syndrome - A Cardiac Channelopathy: Case ReportBrugada Syndrome - A Cardiac Channelopathy: Case Report
Brugada Syndrome - A Cardiac Channelopathy: Case Report
Manievelraaman Kannan
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Manievelraaman Kannan
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGNCOLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
Manievelraaman Kannan
Allergic Acute Coronary Syndrome - KOUNIS SYNDROME
Allergic Acute Coronary Syndrome - KOUNIS SYNDROMEAllergic Acute Coronary Syndrome - KOUNIS SYNDROME
Allergic Acute Coronary Syndrome - KOUNIS SYNDROME
Manievelraaman Kannan
Abnormal Uterine Bleeding (AUB) -Etiopathogenesis
Abnormal Uterine Bleeding (AUB) -EtiopathogenesisAbnormal Uterine Bleeding (AUB) -Etiopathogenesis
Abnormal Uterine Bleeding (AUB) -Etiopathogenesis
Manievelraaman Kannan
Small Intestine TB (Tuberculosis)
Small Intestine TB (Tuberculosis)Small Intestine TB (Tuberculosis)
Small Intestine TB (Tuberculosis)
Manievelraaman Kannan

Recently uploaded (20)

PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
Local Anesthetic Use in the Vulnerable Patients
Local Anesthetic Use in the Vulnerable PatientsLocal Anesthetic Use in the Vulnerable Patients
Local Anesthetic Use in the Vulnerable Patients
Reza Aminnejad
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptxOne Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
Wahid Husein
Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.
helanmariaarockkiasa
Regulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdfRegulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdf
MedicoseAcademics
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
Biography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo GiordanoBiography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo Giordano
Dr. Vincenzo Giordano
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
Dr. Anindya
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Ganapathi Vankudoth
Hemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomyHemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomy
26d78y5bwr
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDiabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Dr Anik Roy Chowdhury
4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx
NashiedaLilangBuale
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
Local Anesthetic Use in the Vulnerable Patients
Local Anesthetic Use in the Vulnerable PatientsLocal Anesthetic Use in the Vulnerable Patients
Local Anesthetic Use in the Vulnerable Patients
Reza Aminnejad
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptxOne Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
Wahid Husein
Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.
helanmariaarockkiasa
Regulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdfRegulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdf
MedicoseAcademics
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
Biography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo GiordanoBiography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo Giordano
Dr. Vincenzo Giordano
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
Dr. Anindya
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Ganapathi Vankudoth
Hemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomyHemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomy
26d78y5bwr
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDiabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Dr Anik Roy Chowdhury
4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx
NashiedaLilangBuale
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37

Leptospirosis Protocol for NABH accredition

  • 1. LEPTOSPIROSIS - DIAGNOSIS & MANAGEMENT GUIDELINES MODIFIED FAINES CRITERIA (2012) PRESUMPTIVE DIAGNOSIS: PART A or PART (A+B) = 26 or more PART (A+B+C) = 25 or more POSSIBLE DIAGNOSIS: Scores between 20 and 25 CASE DEFINITION (ICMR & WHO-SEAR) Suspected case Acute febrile illness with: Myalgia (especially calf tenderness) Conjunctival su ff usion Headache Prostration History of exposure to possible leptospira-contaminated environment Probable case Suspected case with: Rapid diagnostic test positivity (IgM ELISA or MSAT) Con fi rmed case Suspected or Probable case with: Isolation of leptospira in culture or PCR positivity or MAT (single titre of 1:400 or above / fourfold rise in serial titres) CLINICAL (PART-A) EPIDEMIOLOGICAL (PART-B) LABORATORY (PART-C) Headache 2 Rainfall 5 Isolation by culture** DIAGNOSIS CERTAIN Fever 2 Contact with contaminated environment 4 Positive PCR 25 Temperature > 39* C 2 Animal contact 1 ELISA IgM Positive* 15 Conjunctival su ff usion 4 MSAT Positive* 15 Meningism 4 MAT* (Single high titre or Rising titre - 4x rise) 15 Myalgia 4 Conjunctival su ff usion + Meningism + Myalgia 10 *any one of the tests only should be considered for scoring Jaundice 1 Albuminuria / Azotemia 2 Hemoptysis / Dyspnea 2 **Ideal time for culture Blood - Within 10 days Urine - 10 to 30 days CSF - Within 5 to 10 days
  • 2. Leptospirosis - Suspected / Probable / Con fi rmed 90% of cases are Mild Leptospirosis (Fever, myalgia, conjunctival suffusion, headache BUT NO JAUNDICE) Around 10% cases are Moderate / Severe Leptospirosis (Fever, myalgia, conjunctival suffusion, headache + JAUNDICE +/- Multi-organ involvement Based on clinical spectrum OP Treatment Doxycycline 100mg PO BD x 7 days or Amoxicillin 500mg PO TDS x 7 days or Ampicillin 500mg PO TDS x 7days or Azithromycin 500mg PO OD x 3 days Other supportive Rx* *advise adequate hydration, bed rest, antipyretics etc. RED FLAG SIGNS (tachypnea, tachycardia disproportionate to fever, shock, altered sensorium, oliguria, bleeding manifestations etc.) IP Treatment (Antibiotic Rx +/- Organ speci fi c Rx) Antibiotic therapy: Penicillin 1.5 million units IV QID x 7 days or Ceftriaxone 1g IV BD x 7 days or Doxycycline 200mg IV stat, then 100mg IV BD x 7days (Doxycycline contraindicated in pregnancy) Organ speci fi c therapy: RENAL: renal involvement is common. Mild - only proteinuria and no RFT derangement: No intervention Severe - AKI: Fluid management +/- diuretics, electrolyte correction, avoid nephrotoxic drugs, avoid hypotension and hypovolemia +/- RRT (if indicated by standard RRT guidelines) HEPATIC: acute liver failure is rare. Avoid precipitating factors of hepatic encephalopathy - drugs (hepatotoxic drugs, sedatives etc.), hypovolemia, hypokalemia, alkalosis, constipation, UGI bleeding. Jaundice, Hepatomegaly: No intervention Hepatic encephalopathy: lactulose, rifaximin etc. LUNG: Most dangerous complication ARDS / Pulmonary hemorrhage: Continuous O2 therapy, Mechanical ventilation (if indicated) HEART: Myocarditis / Arrhythmia: treatment of speci fi c arrhythmia Shock: treat hypovolemia with fl uid replacement. If not responding, add dopamine or dobutamine. HEMATOLOGICAL: Thrombocytopenia: Platelet transfusion (if indicated) Coagulopathy: Vit.K 5-10mg IV x 3 days +/- Fresh Frozen Plasma DIC: FFP +/- blood transfusion NEUROLOGICAL: Aseptic meningitis: Symptomatic and supportive management. Hypokalemic paralysis: IV Potassium supplementation MUSCULOSKELETAL: Myalgia / Myositis / Rhabdomyolysis : Monitor CPK levels, adequate hydration, monitor urine output and serum electrolytes. Arthralgia: No intervention +/- analgesic-antipyretics All Absent Any one or more is present Always rule out other tropical diseases. Mixed infections are common. Important differential diagnosis include: -Malaria -Scrub typhus -Dengue -Hepatitis -Enteric fever etc.
  • 3. Leptospirosis Zoonotic Pathogenic spirochete Leptospira interrogans Rodents and Cattle excrete these organisms in their urine, which contaminates soil and waterbodies Mode of transmission: contact of abraded skin or mucous membrane with contaminated environment Incubation period: Average 5-14 days with a range 2- 30 days Risk factors: o Heavy rainfall and water logging o Natural disasters like floods o Seasonal at the onset of monsoon o Farmers o Agricultural field workers o Fishermen o Sewer workers o Livestock handlers o Mason o Residence in endemic area Presentation spectrum: o Anicteric Leptospirosis: (90%) Mild form presents like Acute undifferentiated fever o Icteric Leptospirosis: (5-10%) Moderate-Severe form o Weils Disease (0-5%) Severe form When to suspect Leptospirosis? o Acute febrile illness + Risk factors + one or more of the following: Headache Myalgia Prostration Calf muscle tenderness Conjunctival suffusion Oliguria / Frothy urine Jaundice Haemorrhagic manifestations Meningeal irritation Nausea, Vomiting, Abdominal pain, Diarrhoea Lab investigations to support diagnosis: (Blood, CSF, Urine sample) o MAT titre of 100/200/400 or above based on endemicity (preferred) o IgM based immune assays o Seroconversion or Four-fold rise in MAT titre between acute and convalescent sera o Direct isolation of organism o PCR test
  • 4. Lab investigations to assess severity: o CBC, ESR o RFT, LFT o S. Electrolytes o Urine Routine examination o CPK o CXR, ABG Management: o IVF and correction of electrolytes o Mild cases: Tab. Doxycycline 100mg PO BD X 7 days (preferred) or Tab. Azithromycin 500mg PO OD X 3 days o Moderate / Severe cases: Inj. Penicillin 1.5 million units IV or IM Q6H X 7 days or Inj. Ceftriaxone 2g IV OD X 7 days o Chemoprophylaxis: Tab. Doxycycline 200mg PO once a week or Tab. Azithromycin 250mg PO once/ twice a week
  • 5. DIAGNOSTIC: A + B = /> 26 OR A + B + C = /> 25 POSSIBLE: A + B = Between 20 to 25 CRITERIA